158 related articles for article (PubMed ID: 3190801)
1. Muroctasin. A new muramyl dipeptide derivative, MDP-Lys(L18).
Arzneimittelforschung; 1988 Jul; 38(7A):951-1074. PubMed ID: 3190801
[No Abstract] [Full Text] [Related]
2. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
Nagao S; Sato K; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity studies of muroctasin.
Shimada H; Hattori C; Sato T
Arzneimittelforschung; 1988 Jul; 38(7A):1031-3. PubMed ID: 3056424
[TBL] [Abstract][Full Text] [Related]
4. Specific binding sites of muroctasin on murine macrophages.
Akasaki M; Masayasu H; Tsukada W; Takegoshi T
Arzneimittelforschung; 1988 Jul; 38(7A):978-80. PubMed ID: 3190804
[TBL] [Abstract][Full Text] [Related]
5. Activation of immune responses by muroctasin.
Akasaki M
Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
[TBL] [Abstract][Full Text] [Related]
6. Local tolerance of muroctasin injection in rabbits.
Nakashima K; Jindo T; Nomura M
Arzneimittelforschung; 1988 Jul; 38(7A):1038-9. PubMed ID: 3190798
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of non-specific resistance to infection by muroctasin.
Otani T; Une T; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):969-76. PubMed ID: 3056426
[TBL] [Abstract][Full Text] [Related]
8. Production of colony-stimulating factor from macrophages by muroctasin.
Yamaguchi F; Akahane K; Takashi T; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
[TBL] [Abstract][Full Text] [Related]
9. Subacute toxicity of muroctasin in mice and dogs.
Ono Y; Iwasaki T; Sekiguchi M; Onodera T
Arzneimittelforschung; 1988 Jul; 38(7A):1024-7. PubMed ID: 3190795
[TBL] [Abstract][Full Text] [Related]
10. [Muroctasin, a muramyl dipeptide derivative].
Sosnowska D; Dzierzbicka K; Myśliwski A; Kołodziejczyk AM
Postepy Hig Med Dosw; 1992; 46(5):521-30. PubMed ID: 1298958
[TBL] [Abstract][Full Text] [Related]
11. Chronic toxicity of muroctasin in mice.
Ono Y; Sekiguchi M; Aihara K; Onodera T
Arzneimittelforschung; 1988 Jul; 38(7A):1028-30. PubMed ID: 3190796
[TBL] [Abstract][Full Text] [Related]
12. Muroctasin, a muramyl dipeptide derivative. An introductory overview.
Tsubura E; Azuma I; Une T
Arzneimittelforschung; 1988 Jul; 38(7A):951-2. PubMed ID: 3056425
[No Abstract] [Full Text] [Related]
13. Antigenicity study of muroctasin.
Yamaguchi F; Hattori H; Wagai N; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):1034-7. PubMed ID: 3190797
[TBL] [Abstract][Full Text] [Related]
14. Restorative activity of muroctasin on leukopenia associated with anticancer treatment.
Tsubura E; Nomura T; Niitani H; Osamura S; Okawa T; Tanaka M; Ota K; Nishikawa H; Masaoka T; Fukuoka M
Arzneimittelforschung; 1988 Jul; 38(7A):1070-4. PubMed ID: 3190800
[TBL] [Abstract][Full Text] [Related]
15. [Muramyl dipeptide derivative and its clinical application].
Tsubura E
Kekkaku; 1989 Nov; 64(11):731-9. PubMed ID: 2593464
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of muroctasin in mice.
Matsubayashi K; Takegoshi T
Arzneimittelforschung; 1988 Jul; 38(7A):1015-8. PubMed ID: 3190793
[TBL] [Abstract][Full Text] [Related]
17. [Restorative effect of muroctasin; MDP-Lys (L18) [DJ-7041] on leukopenia in urogenital cancer patients treated with chemotherapy].
Oishi K; Takeuchi H; Yoshida O; Nakagawa K; Fukuyama T; Okamoto K; Kihara Y; Okuno H; Shirahase T; Tomoyoshi T
Hinyokika Kiyo; 1989 Mar; 35(3):527-36. PubMed ID: 2660519
[TBL] [Abstract][Full Text] [Related]
18. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
Nagao S; Sato K; Osada Y
Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
[TBL] [Abstract][Full Text] [Related]
19. Induction of colony-stimulating factor and stimulation of stem cell proliferation by injection of muroctasin.
Yamaguchi F; Akasaki M; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):980-3. PubMed ID: 3263869
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of muroctasin on experimental leukopenia induced by cyclophosphamide or irradiation in mice.
Nakajima R; Ishida Y; Yamaguchi F; Otani T; Ono Y; Nomura M; Une T; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):986-92. PubMed ID: 3263871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
